Dr. Neeraj R. Ramvishal-Agrawal

I have over twenty years of experience as a hematologist-oncologist focusing in hematologic malignancies, leukemias, lymphomas, myeloma, and myelodysplastic and myeloproliferative syndromes. My patient care philosophy stresses interactive discussions with patients and their families on what to expect from the illness and treatment options, making sure that all their concerns and questions are addressed. Caring for patients with cancer is complex and my care team is dedicated to helping patients with the family, social, emotional, and financial issues, in addition to compassionate medical care. Dr. Kirby is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). Her top areas of expertise are Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Follicular Lymphoma, and Bone Marrow Aspiration.

Jeffrey Jorgensen is a Hematologist in Cary, North Carolina. Dr. Jorgensen is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic B-Cell Leukemia (CBCL), and Bone Marrow Transplant.

I study disorders of the bone marrow and bone marrow failure syndromes. I also see some leukemias and lymphomas and other blood malignancies. Duke offers a very personalized, individualized level of care to each patient. Nobody is the same, so we take the whole patient, we listen to them, and we offer our best recommendations for treatment options. We offer some of the latest treatment options that are available, usually in the setting of a clinical trial. If not, we offer the latest advancement in the field. When I was going through medical school, molecular biology was the new field. Everything was being described as a new cancer-causing gene. And to me that was so appealing – we’re going to figure out what causes cancer and new ways to treat it. That’s what really brought me into the hematology oncology world – things were being discovered that were new and exciting and hopefully would lead to new treatment options. Duke offers an extremely high standard of care. Though we’re not always successful and the disease sometimes wins, our goal is to give the patients the best possible care. Dr. De Castro Iii is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration.